Introduction: We aimed to investigate factors defining amyloid β (1-42) (Aβ1-42) adsorption during preanalytical workup of cerebrospinal fluid (CSF).
Methods: CSF was transferred to new tubes ≤4 times. Variables tested were different polypropylene tube brands, volumes, CSF Aβ1-42 concentrations, incubation times, pipettes, vortex intensities, and other CSF proteins, including hyperphosphorylated tau and Interleukin 1 Receptor Accessory Protein (IL-1RAcP). An enquiry assessed the number of transfers in current practice.
Results: In diagnostic practice, the number of transfers varied between 1 and 3. Every tube transfer resulted in 5% loss of Aβ1-42 concentration, even 10% in small volumes. Adsorption was observed after 30 seconds and after contact with the pipette tip. Tube brand, vortexing, or continuous tube movement did not influence adsorption. Adsorption for Aβ1-40 was similar, resulting in stable Aβ1-42/Aβ1-40 ratios over multiple tube transfers.
Discussion: We confirmed that adsorption of CSF Aβ1-42 during preanalytical processing is an important confounder. However, use of the Aβ1-42/Aβ1-40 ratio overcomes this effect and can therefore contribute to increased diagnostic accuracy.
Keywords: Adsorption; Alzheimer's disease; Amyloid β (1–40); Amyloid β (1–42); Biobanking; Biomarkers; Cerebrospinal fluid; Preanalytical variation; Ratio Aβ(42)/Aβ(40).
Copyright © 2017 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.